Conveyance of Materials. Within thirty (30) days after the Effective Date, Schering will transfer to Molecular Insight the materials in relation to the Schering Patent, including as examples benzamide compound samples and lyophilized vials as listed in ANNEX 2.6 to this Agreement, which are in Schering's possession on the Effective Date.. Delivery shall be FOB Schering AG or any other location at which Schering stores such materials, but will be, otherwise, free of additional charge. Schering will provide the materials to Molecular Insight without warranty of quality or fitness for a particular purpose or any other warranty, express or implied.
Appears in 2 contracts
Sources: License, Development and Commercialization Agreement (Molecular Insight Pharmaceuticals, Inc.), License, Development and Commercialization Agreement (Molecular Insight Pharmaceuticals, Inc.)